KING OF PRUSSIA, Pa.; Aug. 13, 2024 (Business Wire) – Clinical trial solutions software innovator Greenphire has been honored with numerous 2024 awards, including a “Best Place to Work” designation from Philadelphia Business Journal for the ninth time and designation as one of the Inc. 5000 for the tenth time. These awards are in addition to the “Best Overall Patient Engagement Service” MedTech Breakthrough award Greenphire received earlier this year.
“Receiving the Inc. 5000 designation for a tenth year in 2024 is a huge achievement,” said Greenphire CEO Jim Murphy. “There’s a lot of competition to be counted amongst the fastest growing American companies, and this award acknowledges the immense impact of our clinical trial solutions and success of our company.”
“We create measurable value and efficiencies for sponsors, CROs, sites, and patients all over globe thanks to our incredible team’s energy, passion, creativity and dedication,” Murphy continued, “and we’re thrilled to again be honored as a ‘Best Place to Work.’”
Greenphire is also a finalist for two Timmy Awards: “Best Tech for Good” and “Best Tech Work Culture.” Final award results will be announced in the fall.
Delve deeper into the groundbreaking initiatives, cutting-edge technology, and unparalleled service enhancements at Greenphire.com.
About Greenphire
Greenphire is a Thoma Bravo-backed software company specializing in providing comprehensive solutions for streamlining clinical trials. With a focus on optimizing patient and site experiences, Greenphire offers innovative software for travel and logistics support, automated patient and site payment solutions, and trial budgeting software and analytics. Greenphire Means GO.
